Twist Bioscience Reports Third Quarter Fiscal 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Twist Bioscience Corporation (TWST) Tops Q3 EPS by 6c, Revenues Beat
August 6, 2020 4:51 PM EDTTwist Bioscience Corporation (NASDAQ: TWST) reported Q3 EPS of ($0.67), $0.06 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $21.2 million versus the consensus estimate of $14.17 million.
We posted a strong quarter of revenue growth for both synthetic biology and next generation sequencing (NGS) along with solid orders and a robust pipeline of opportunities across our silicon-based technology platform, said Emily M. Leproust,... More



